Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dificlir 40mg/ml oral suspension
0501070ACBBABAB
|
Dificlir | Fidaxomicin | Infections | No data available |
|
Diflucan 200mg/100ml solution for infusion vials
0502010B0BBAEAE
|
Diflucan | Fluconazole | Infections | No data available |
|
Diflucan 50mg/25ml solution for infusion vials
0502010B0BBADAD
|
Diflucan | Fluconazole | Infections | No data available |
|
Diflucan One 150mg capsules
0502010B0BBAIAB
|
Diflucan | Fluconazole | Infections | No data available |
|
Diloxanide 10mg/5ml oral liquid
0504020G0AAAFAF
|
Diloxanide furoate | Diloxanide furoate | Infections | No data available |
|
Diloxanide 40mg/5ml oral liquid
0504020G0AAAIAI
|
Diloxanide furoate | Diloxanide furoate | Infections | No data available |
|
Diloxanide 500mg tablets
0504020G0AAAAAA
|
Diloxanide furoate | Diloxanide furoate | Infections | No data available |
|
Diloxanide 50mg/5ml oral liquid
0504020G0AAAGAG
|
Diloxanide furoate | Diloxanide furoate | Infections | No data available |
|
Diloxanide 90mg/5ml oral liquid
0504020G0AAAHAH
|
Diloxanide furoate | Diloxanide furoate | Infections | No data available |
|
Dolutegravir 10mg tablets
0503010AHAAABAB
|
Dolutegravir | Dolutegravir | Infections | No data available |
|
Dolutegravir 25mg tablets
0503010AHAAACAC
|
Dolutegravir | Dolutegravir | Infections | No data available |
|
Dolutegravir 5mg/Abacavir 60mg/Lamivudine 30mg disp tab SF
0503010AZAAAAAA
|
Dolutegravir/Abacavir/Lamivudine | Dolutegravir/Abacavir/Lamivudine | Infections | No data available |
|
Doravirine 100mg/Lamivudine 300mg/Tenofovir disoproxil 245mg
0503010ASAAAAAA
|
Doravirine/lamivudine/tenofovir disoproxil | Doravirine/lamivudine/tenofovir disoproxil | Infections | No data available |
|
Doribax 500mg powder for solution for infusion vials
0501022C0BBAAAA
|
Doribax | Doripenem | Infections | No data available |
|
Doripenem 500mg powder for solution for infusion vials
0501022C0AAAAAA
|
Doripenem | Doripenem | Infections | No data available |
|
Doxylar 50mg capsules
0501030I0BCABAA
|
Doxylar | Doxycycline hyclate | Infections | No data available |
|
Duvimex 800mg dispersible tablets
0503021C0BDAAAE
|
Duvimex | Aciclovir | Infections | No data available |
|
Ecalta 100mg pdr and solvent for concentrate for inf vials
0502040A0BBAAAA
|
Ecalta | Anidulafungin | Infections | No data available |
|
Ecalta 100mg pdr for concentrate for inf vials
0502040A0BBABAB
|
Ecalta | Anidulafungin | Infections | No data available |
|
Edurant 25mg tablets
0503010AGBBAAAA
|
Edurant | Rilpivirine | Infections | No data available |
|
Efavirenz 100mg capsules
0503010D0AAABAB
|
Efavirenz | Efavirenz | Infections | No data available |
|
Efavirenz 200mg capsules
0503010D0AAAAAA
|
Efavirenz | Efavirenz | Infections | No data available |
|
Efavirenz 30mg/ml oral solution sugar free
0503010D0AAAEAE
|
Efavirenz | Efavirenz | Infections | No data available |
|
Efavirenz 50mg capsules
0503010D0AAACAC
|
Efavirenz | Efavirenz | Infections | No data available |
|
Elbasvir 50mg / Grazoprevir 100mg tablets
0503032I0AAAAAA
|
Elbasvir/grazoprevir | Elbasvir/grazoprevir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.